$Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide and their combination in severe asthma: a post-hoc analysis$

Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide and their combination in severe asthma: a post-hoc analysis

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Shrimanker, R, Keene, O, Hynes, G, Wenzel, S, Yancey, S, Pavord, I
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	American Thoracic Society 2019

Míreanna comhchosúla

Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma
de réir: Shrimanker, R, et al.
Foilsithe / Cruthaithe: (2018)

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
de réir: Price, D, et al.
Foilsithe / Cruthaithe: (2019)

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
de réir: David B. Price, et al.
Foilsithe / Cruthaithe: (2019-08-01)

Diagnostic possibility of the combination of exhaled nitric oxide and blood eosinophil count for eosinophilic asthma
de réir: Jiang-Hua Li, et al.
Foilsithe / Cruthaithe: (2021-08-01)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
de réir: Howell, I, et al.
Foilsithe / Cruthaithe: (2024)

Biomarkers for severe eosinophilic asthma.
de réir: Yancey, S, et al.
Foilsithe / Cruthaithe: (2017)

Treatment Resistance in Severe Asthma Patients With a Combination of High Fraction of Exhaled Nitric Oxide and Low Blood Eosinophil Counts
de réir: Yuki Hoshino, et al.
Foilsithe / Cruthaithe: (2022-04-01)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
de réir: Imran Howell, et al.
Foilsithe / Cruthaithe: (2024-07-01)

Does a composite score combining peripheral blood eosinophils (PBE) and exhaled nitric oxide (FeNO) accurately predict a sputum eosinophilia?
de réir: Connolly, CM, et al.
Foilsithe / Cruthaithe: (2017)

Both fractional exhaled nitric oxide and sputum eosinophil were associated with uncontrolled asthma
de réir: Gao J, et al.
Foilsithe / Cruthaithe: (2018-04-01)

Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis
de réir: Buendía, JA, et al.
Foilsithe / Cruthaithe: (2022)

Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis
de réir: Jefferson Antonio Buendía, et al.
Foilsithe / Cruthaithe: (2022-06-01)

The use of exhaled nitric oxide in the management of asthma.
de réir: Pavord, I, et al.
Foilsithe / Cruthaithe: (2008)

IL-5 antagonism reverses priming and activation of eosinophils in severe eosinophilic asthma
de réir: Luo, J, et al.
Foilsithe / Cruthaithe: (2024)

Long-Term Adjustment of Stable Asthma Treatment with Fractional Exhaled Nitric Oxide and Sputum Eosinophils
de réir: M. Malerba, et al.
Foilsithe / Cruthaithe: (2012-09-01)

Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide
de réir: Couillard, S, et al.
Foilsithe / Cruthaithe: (2021)

The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.
de réir: Berry, M, et al.
Foilsithe / Cruthaithe: (2005)

Evaluation of potential continuation rules for mepolizumab treatment of severe eosinophilic asthma.
de réir: Gunsoy, N, et al.
Foilsithe / Cruthaithe: (2017)

Management and mechanisms of severe eosinophilic asthma
de réir: Shrimanker, R
Foilsithe / Cruthaithe: (2020)

Annual Fractional Exhaled Nitric Oxide Measurements and Exacerbations in Severe Asthma
de réir: Abe Y, et al.
Foilsithe / Cruthaithe: (2020-12-01)

Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.
de réir: Bel, E, et al.
Foilsithe / Cruthaithe: (2014)

Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma
de réir: Jie Gao, et al.
Foilsithe / Cruthaithe: (2018-05-01)

Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis
de réir: Charlene M. Prazma, et al.
Foilsithe / Cruthaithe: (2019-05-01)

Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma
de réir: Yancey, S, et al.
Foilsithe / Cruthaithe: (2016)

Will exhaled nitric oxide monitoring become routine in managing asthma?
de réir: Pavord, I, et al.
Foilsithe / Cruthaithe: (2009)

Mepolizumab treatment in patients with severe eosinophilic asthma.
de réir: Ortega, H, et al.
Foilsithe / Cruthaithe: (2014)

Fractional exhaled nitric oxide non-suppression in asthma
de réir: Couillard Castonguay, S
Foilsithe / Cruthaithe: (2021)

Measurements of fractional exhaled nitric oxide in pediatric asthma
de réir: Youn-Soo Hahn
Foilsithe / Cruthaithe: (2013-10-01)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
de réir: Shrimanker, R, et al.
Foilsithe / Cruthaithe: (2017)

Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.
de réir: Ortega, H, et al.
Foilsithe / Cruthaithe: (2016)

The effect of oral corticosteroids on circulating type-2 cytokine producing cells in patients with severe eosinophilic asthma
de réir: Hynes, G, et al.
Foilsithe / Cruthaithe: (2018)

Benralizumab in severe eosinophilic asthma in real life: confirmed effectiveness and contrasted effect on sputum eosinophilia versus exhaled nitric oxide fraction – PROMISE
de réir: Florence Schleich, et al.
Foilsithe / Cruthaithe: (2023-11-01)

A novel CT scoring system differentiates admissions secondary to eosinophilic from non-eosinophilic asthma
de réir: Hynes, G, et al.
Foilsithe / Cruthaithe: (2017)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
de réir: Steven W. Yancey, et al.
Foilsithe / Cruthaithe: (2019-09-01)

Fractional exhaled Nitric Oxide monitoring in paediatric asthma management
de réir: Jones, N, et al.
Foilsithe / Cruthaithe: (2017)

Fractional Exhaled Nitric Oxide (FeNo) in Different Asthma Phenotypes
de réir: Bilun Gemicioglu M.D. Ph.D., et al.
Foilsithe / Cruthaithe: (2014-09-01)

The Fraction Exhaled Nitric Oxide as a Biomarker of Asthma Control
de réir: Fernanda Cruvinel de Abreu, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Predictive Value of Exhaled Nitric Oxide and Blood Eosinophil Count in the Assessment of Airway Eosinophilia in COPD
de réir: Antus B, et al.
Foilsithe / Cruthaithe: (2020-08-01)

Exhaled nitric oxide in the diagnosis of asthma in adults: a systematic review.
de réir: Harnan, S, et al.
Foilsithe / Cruthaithe: (2017)

Relationship between fraction of exhaled nitric oxide and peripheral eosinophilia in asthma
de réir: Jane S. Afriyie-Mensah, et al.
Foilsithe / Cruthaithe: (2024-12-01)